ÂÜÀòÉç¹ÙÍø

TOC: J Med Mar

Introduction

Journal of Medical Marketing, 9(2)

 : : : TOC

: : journals

 

Relevant ARCategory:  


Interesting times
Brian D Smith []

Resisting persuasion: Building defences against competitors’ persuasive attacks in the context of war-gaming methodology
Donna Kelly and Michael D’Aust Garcia [] [Google Scholar]

Myth, reality and requirements in pharmaceutical Key Account Management
Brian D Smith [] []

Changes in the delivery of primary care and in private insurers’ role in United Kingdom, Italy, Germany, Switzerland and France
Daniel Simonet [] [Google Scholar]

Pharmaceutical product differentiation: A strategy for strengthening product pipeline and life cycle management
Rajesh Dubey and Jayashree Dubey [] []

Beyond transactional management: Transformational lessons for Pharmaceutical sales and marketing managers
Engelbert Tjeenk Willink [] []

Research Watch
Brian D Smith []

Coming of age: An introduction to our special section on European Continuing Medical Education
Eugene Pozniak [] []

A concise framework for medical education terminology
Erin Kingshill, Bruce LaDuke and Steve Willis [] []

European CME accreditation
Robin D Stevenson [] []

An overview of CME/CPD credit systems around the world
Abi Sriharan, Ron Murray, Helios Pardell and Honorio Silva [] []

HIV and the Body: A model of independent medical education
James Osborn [] []

eLearning in continuing medical education: A comparison of knowledge gain and learning efficiency
Peter A Henning and Annekatrin Schnur [] []

CME: From hard reality to virtual reality
Carolyn Hodgkin [] []

The ESMO CME program: How practicing oncologists can maintain their knowledge in the E-era? Certification and recertification opportunities
Andres Cervantes, Doris Vola, Svetlana Jezdic and Rolf Stahel [] []

Changing continuing medical education: An opportunity to improve physician education and patient care around the world
Lawrence Sherman [] []

Presence, alignments and shared authenticity: Considering the new era of engagement between experts and the pharmaceutical industry
Emma D’Arcy [] []